This document provides practical illustrations on how to use key global resources related to the procurement of safe-injection equipment. It is intended for use by country decision-makers responsible for selecting and procuring good-quality safe-injection equipment.

Publication date: March 2010

Region: Global

This case profile of the vaccine vial monitor (VVM) is the first in a series of profiles intended to illustrate the product introduction process.

Author: Kristensen D; Burns M

Publication date: 2007

Region: Global

PATH’s Safe Water Project joined a number of partners in an effort to monitor and better understand the increased use of a water-treatment product, WaterGuard, among groups of new mothers in Malawi. The chlorine-based water treatment product was made available to pregnant women at antenatal care clinics as part of a hygiene kit. Uptake and use of the product rose sharply, not only among these women, but also among friends and relatives. PATH conducted qualitative research involving in-depth interviews to better understand why this uptake occurred.

Publication date: March 2011

Region: Africa

This publication details PATH's pilot project to support distribution of effective household water treatment and safe storage products for low-income populations via local health workers. The pilot took place in two districts in Can Tho, Vietnam.

Publication date: November 2011

Region: Asia

PATH’s Safe Water Project is implementing innovative methods to enable commercial enterprises to produce, distribute, sell, and maintain effective household water treatment and storage products for low-income populations in multiple developing countries around the world. This project brief summarizes the findings of PATH's work with the US Centers for Disease Control and Prevention to investigate the effects of an innovative program that promoted a chlorine disinfectant for treatment of water at home to pregnant women seeking antenatal care.

Author: Kols A

Publication date: July 2011

Region: Africa

Part of series: Safe water briefs

Author: Wittet S

Publication date: 2002

Region: Global

This overview describes how PATH has developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global health contain an aluminum salt adjuvant or its equivalent (such as aluminum hydroxide, aluminum phosphate, or calcium phosphate) and would benefit from the technology.

Publication date: October 2012

Region: Global

This fact sheet provides an overview of PATH's work in protecting children from diarrheal disease.

Publication date: September 2012

Region: Global

Part of series: PATH's areas of focus fact sheets

This document is part of a series that describes the serious risk of freezing vaccines and provides tools to reduce freezing in the cold chain. The materials contain current WHO-recommended freeze-prevention strategies targeted toward all levels of storage and transport of vaccines.

Publication date: 2003

Region: Global

This policy report highlights the essential role that public-private partnerships play in driving global health product development and offers insights into the key components of successful multi-sector partnerships led by PATH.

Publication date: March 2013

Region: Global

The Optimize project, a collaboration between PATH and the World Health Organization, commissioned this white paper to examine the issues influencing vaccine producer willingness to advance, adopt, and commercialize value-added technologies for vaccines for low-income and lower-middle-income country markets.

Author: Gilchrist S

Publication date: November 2009

Region: Global

This document is intended to start discussions around quantifying the need for safe injection equipment and the amount of infectious sharps waste produced by testing and treatment programs for diseases such as HIV/AIDS, tuberculosis, and malaria. The analysis was developed to support advocacy efforts to integrate injection safety as an essential element of all health care programs.

Publication date: June 2009

Region: Global

This four-page brochure tells the story of the Uniject device--how it grew from a concept to an easy-to-use, all-in-one injection device that will be used to vaccinate every newborn in Indonesia against hepatitis B and to help eliminate maternal and neonatal tetanus globally. The publication covers the development, evaluation, licensing, production, and design and function of Uniject. Photographs and a timeline of Uniject's history included.

Author: E.Simpson

Publication date: 2003

Region: Global

Launched in 2002, this PATH website explores rapid diagnostic tests for infectiuos diseases, and provides information useful to international public health officials.

Publication date: 2008

Region: Global

Part of series: Websites

The global diabetes epidemic impacts pregnant women and their babies. This poster describes a rapid, low-cost, non-fasting screening assay proposed by PATH to be used at antenatal care visits. The test would enable interventions to prevent or delay diabetes in the mother and child.

Publication date: July 2012

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, easy-to-read, low-cost test for malaria.

Publication date: May 2009

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work to develop rapid tests for cervical cancer.

Publication date: April 2012

Region: Global

Part of series: Technology Updates

This guide introduces the retinol binding protein enzyme immunoassay (RBP-EIA) to potential advocates and users, and provides information about its prospective role in public health.

Author: Hix J; Levin C; Gorstein J

Publication date: 2003

Region: Global

This document serves as a guide to phlebotomists and a training aid in the proper methods of obtaining blood samples for analysis by the retinol-binding protein enzyme immunoassay (RBP-EIA) used in testing for vitamin A deficiency.

Publication date: 2005

Region: Global

This document summarizes available evidence for the validation and establishment of a rapid, field-based tool for the assessment of vitamin A deficiency using the retinol-binding protein immunoassay (RBP-EIA) test.

Publication date: 2006

Region: Global